chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, HA, loss of appetite and weakness x 3 days. Fell twice and hit head as a result, resulting in ER visit to close bleeding wound.
Fever; nausea; headache; chills; cough; fatigue; This is a spontaneous report from a contactable consumer (reported for self).  A 23-year-old non pregnant female patient received second dose of BNT162B2 (Solution for injection, Lot number: unknown) via an unspecified route of administration, on 05Feb2021 (at the age of 23-year-old) 02:00 PM, in Left arm as dose 2, single for Covid-19 immunization. The patient had Known allergies: Penicillin. Concomitant medications were not provided. The patient received first dose of BNT162B2 (Solution for injection, Lot number: unknown) via an unspecified route of ad-ministration, on 15Jan2021 (at the age of 23-year-old) 12:00 Pm, in Left arm as dose 1, single for Covid-19 immunization. She did not have any other vaccine in four weeks. On 06Feb2021 04:45 PM, the patient experienced Fever, nausea, headache, chills, cough, and fatigue. The patient did not receive any treatment for events. The outcome of the events was reported as recovering. She did not have covid prior vaccination and was not tested for it post vaccination.   No follow-up attempts were Possible. Information on lot/batch could not be obtained.
This spontaneous report was received from a medical assistant and refers to a 68 year old, non pregnant female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. It was stated that the patient did not have drug reactions or allergies. On 20-APR-2018, the patient was vaccinated with PNEUMOVAX 23 lot number R000579 with expiration date on 09-SEP-2019, as a preventive of pneumococcal disease (strength, dose, route of administration and anatomical location were not reported). On 20-APR-2018, reported as "immediately after injection", the patient experienced rash on chest, severe back spasms (muscle spasms), flushing and vomiting. On the same day, 10 minutes after symptoms started and by the time the physician finished his assessment of patient all aforementioned events were resolved with no intervention. The reporter did not assess the causal relationship between therapy with PNEUMOVAX 23 and the events. Additionally, it was stated that the physician was requesting a lot check for PNEUMOVAX 23. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1804USA009456.
Immunizations given two days ago, now upper thigh red, swollen,hot to touch. Diagnosed: cellulitis.
SEVERE HEADACH AND NAUSEA THAT MOVED TO COGNITIVE EFFECTS OF DISORIENTATION, VISUAL PROCESSING ISSUES, INABILITY TO DRIVE, DECREASE REACTION TIME, CONFUSION, BLEEDING ORAL MUCOSA. PATIENT DID NOT GO TO THE DOCTOR BUT DID TAKE ASPIRIN 81MG ONCE DAILY.
Patient called on 2/11/2021 and stated that she had some redness and swelling at the injection site.  Patient also stated she had a baseball sized knot on her arm at the injection site.  Patient was seen at the Clinic on 2/11/2021 at 9:40 am.  Patient was prescribed Benadryl and Prednisone.
I got the Pfizer COVID vaccine and had no side effects except some tingling in my fingers. I already reported it to VAERS; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "I got the Pfizer COVID vaccine and had no side effects except some tingling in my fingers. I already reported it to VAERS".  Additional information: Described tingling in her fingers after receiving the Pfizer COVID vaccine that has already subsided. It was mentioned this to reporter in casual conversation. Paraphrased "I got the Pfizer COVID vaccine and had no side effects except some tingling in my fingers. I already reported it to VAERS." Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Foreign record. Missed #4 dose of IPV 7/6/09 which was admin age 9. IPV given 8/31/16 dose not needed. No adverse symptoms.
patients may have been administered improperly stored vaccines; This spontaneous report was received from a medical assistant, refers to a currently 4 year old female patient. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. The patient's concomitant medication included diluent.  On an unknown date, the patient may have been vaccinated with improperly stored doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, rHA (recombinant Human albumin) (PROQUAD) lot# S012468, expiration date; lot# S017245, expiration date 01-DEC-2020 and varicella virus vaccine live (oka/merck) (VARIVAX) lot# S015462, expiration date 20-MAY-2021 for prophylaxis (exact doses, routes of administration and anatomical locations were not reported for all vaccines) (product storage error). The vaccines experienced the temperature excursion of 40 degrees Fahrenheit for 2 hours and 30 minutes. Data logger was involved. There were no previous excursions reported. It was unknown if the diluent used to reconstitution of the vaccines was properly stored.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2004USA001910: US-009507513-2004USA002003: US-009507513-1909USA010004:
Patient discovered erythema and 3 cm x 3 cm indurated area at injection site and reported localized reaction to this RN who notified the physician on call to requesting the MD to assess at the bedside. Area was measured and traced to assess for improvement or worsening. Patient is 27 3/7 gestational age and Estimated date of delivery is 03/01/2018. Patient has a OB history of x2 spontaneous vaginal deliveries (1 preterm @ 30 weeks; and x1 fetal demise @ 35 weeks).
Day 11 tested positive; Day 11 tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 18Feb2021 at 09:30 as dose 1, single (Lot number: EN5318), in left arm, on 11Mar2021 at 09:45 as dose 2, single (Lot number: EN6208), in left arm and on 15Nov2021 at 10:00 as dose 3 (booster), single (Lot number: FJ1620) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Seasonal allergies" (unspecified if ongoing), notes: Seasonal allergies; "high cholesterol" (unspecified if ongoing); "borderline high blood pressure" (unspecified if ongoing), notes: borderline high blood pressure. Concomitant medication(s) included: BUPROPION, start date: Jan2008; CETIRIZIN, start date: Jan2008; ACETAMINOPHEN, start date: 21Apr2022, stop date: 24Apr2022; ALEVE, start date: 21Apr2022, stop date: 24Apr2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Day 11 tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: day 11 tested Positive; (2022) Negative, notes: day 16 tested negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient was treated with Paxlovid (lot number:FY5657) form 22Apr2022 to 26Apr2022 for the treatment of COVID-19. Patient was also taking other medications within 2 weeks of starting COVID-19 treatment. Patient had previously received a COVID-19 Vaccine  No follow-up attempts are possible. No further information is expected.
So around 1/30/2021 I started itching all over my body and little red color bumps starting to come to up. I still got some bumps but it seems like they are getting better.  I have tried to taking Benadryl.
Woke up with the feeling that both of my arms were asleep.  I adjusted myself to relief any pressure but nothing improved.  Felt so weak that entire day, and the following 2 days.
chill, night sweats and lo grade temperature at night (99-101.8).  /......occurring11/01-11/04
11/02/05 felt mild discomfort, feverish. until 11-12 started achiness in elbow and shoulder. 11-15 all joints were in pain 11-21 excruciating pain joints and muscles, took Fluricet (did not help). 11-25 started Prednisone (didn't help) 12-17 and 12-21 oxycodone 5 & 10 mg (didn't help) 12-9 hydrocodone 10 mg (didn't help) 1-3-06 Penicillin started taking Royal Jelly 12/22/05 until now (seemed to help).
vaccine affected menstrual cycle by 5 days; spotting prior to menstruating; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. The patient did not receive any other concomitant medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, the patient experienced affected menstrual cycle by 5 days and had spotting prior to menstruating which was very out of the ordinary for her. The clinical outcome of the events of menstrual disorder and spotting menstrual was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a 19 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no illness at the time of vaccination, no history of similar events, no adverse event after any previous vaccination(s), no any food, drug, or vaccine history allergy, no any pre-existing acute illness 30 days prior to vaccination, no history of hospitalization in last 30 days with cause and had no family history of any disease (relevant to vaccination) or allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 211A21A, expiry: 14-DEC-2021) dose was not reported, administered on 27-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-DEC-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20220260967, 20220261014, 20220261042, 20220260995, 20220261011, 20220261030, 20220261048, 20220261000, 20220261022, 20220261024, 20220261043, 20220261039, 20220261063, 20220261092 and 20220210382.
The patient is an 85y/o w/pmh of hypopituitarism and macroprolactinoma, who presented w/weakness, chills after receiving her Covid booster on 10/4/2021, hypotension requiring pressors, possible UTI with 2+ leukoesterase, WBC 12.  She states she was awake the entire night w/chills denies fever, n/v or diarrhea chest pain, shortness of breath, cough or chest pain. On arrival to the ER she had a low grade temp and c/o bilateral leg pain. Chest X-ray shows no acute pulmonary processes. Lactate 2.49, BNP 9,325 s/p 1.8 liters of LR. She was admitted to ICU with hypotension requiring vasopressors, AKI 2/2 hypotension.Additional information for Item 18: Echo EF is estimated at 25-30 %. Moderate tricuspid regurgitation with RVSP of 67 mmHg consistent with severe pulmonary hypertension. Mild aortic regurgitation is present. In comparison to 6/18/20 EF 65-70%.  Diagnosed with stress cardiomyopathy.  Clinically recovering.
Patient with reflux (gastroesophageal) that mom reports was improving before 2nd dose of rotarix. She reports drastic persistent worsening of GER + fussiness since 2nd dose. Not yet but unclear if worsening disease is unrelated to vaccine.
Immediately after receiving vaccine, slight nausea lasted one hour, explosive bowels lasted for 15 mins.
HAIR LOSS; COLD SORES; TINNITUS; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient did not have cold sores before. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855835, and expiry: UNKNOWN) dose was not reported, administered on 15-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 16-DEC-2021, the patient experienced tinnitus. On 22-DEC-2021, the patient experienced cold sores. On an unspecified date, the patient experienced hair loss. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from cold sores, and had not recovered from tinnitus, and hair loss. This report was non-serious.
Breakthrough case admission after 2 vaccines Janssen 5/10/21 Lot# 041A21A;  Pfizer 10/27/22 Lot# GJ3277
pt recvd vax; pt devel flu-like symptoms consisting of aches, nausea & a headache;
4 ER VISITS 1ST. 10/6/21 HIGH BLOOD PRESSURE 220-76 SENT HOME 2ND 10/9/21   CHEST PAIN  BLOOD PRESSURE 161/74  PERICARDIAL EFFUSION    & PNEUMONIA SENT HOME AFTER TREATMENT 3RD 10/13/21  EPIGASTRIC PAIN GALLSTONES LIPASE 35 K   TOOK OUT GALLBLADDER 10/16/21 DISCHARGE 10/17/21 4TH  10/19/21 PANCREATITIS, PNEUMOPERITONEUM, DILATED MAIN PANCREATIC, BILATERAL PLEURAL EFFUSIONS
This case was reported by a physician and described the occurrence of injection site redness in a 11-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). There were no concurrent medications. On an unknown date the subject received unspecified dose of BOOSTRIX. An unspecified amount of time after administration with BOOSTRIX, the subject experienced injection site redness about 2 inches from the injection site. The subject was watched and then was allowed to leave. At the time of reporting the outcome of the event was unspecified.
Fever developed during the evening of 11/21/2001. It was over 103 the afternoon of the 11/22/2001. Family took pt to ER, but did not want to wait the 4 hours it would be before seeing the doctor. Pt's daughter gave alcohol rubs (she's an RN) and managed to break the fever. On 11/22/2001 left upper arm swollen, hot to touch. Pt recovered by 11/24/2001.
This spontaneous report was received from a nurse via a company representative, concerning a 15-year-old male patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions or allergies were not reported. On an unspecified date in May 2015, the patient was vaccinated with the first dose of GARDASIL, intramuscularly (dose, lot number and expiration date were not reported) for prophylaxis. On an unspecified date in May 2017, the patient received the second dose of his human papillomavirus (HPV) vaccination with GARDASIL 9, intramuscularly (dose, lot number and expiration date were not reported). No adverse effects were reported.
Received first does on Sunday October 3, 2021. Began to feel chest tightness and shortness of breath on Tuesday October 5, 2021. Symptoms persisted and worsened over the next 48 hours, so I decided to go to urgent care on Thursday October 7, 2021. The physician assistant suspected pericarditis and placed a stat referral to see a cardiologist and obtain an echogram. I had my initial appointment with the cardiologist on Friday October 8, 2021 who setup the stat echogram. The echogram was able to rule out myocarditis and cardiologist confirmed pericarditis as the diagnosis. I was prescribed colchicine, an anti-inflammatory, for the treatment of pericarditis.
Started noticing Anal Warts, Patient didn't report them to her mother until 20th of October when they were advanced to an uncomfortable stage, Near 20th of October, saw Dr regarding the warts, referred to another Dr, seen on November 4th and November 16th.  Sent to surgeon on November 26th.  1st Surgery to remove outer anal warts was on December 18th.  Patient requires future surgery to remove internal anal warts.  Biopsy on November 16th showed pre-cancerous evolution of warts.
BRAIN FOG; ARM  TINGLING; SORE ARM; FEVER; HEADACHE; FATIGUE; This spontaneous report received from a parent concerned a 25 year old female. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 11:00 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 01-APR-2021, the subject experienced brain fog. On 01-APR-2021, the subject experienced arm tingling. On 01-APR-2021, the subject experienced sore arm. On 01-APR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from brain fog, and fever on 02-APR-2021, arm tingling on 01-APR-2021, and sore arm on 04-APR-2021, and the outcome of headache and fatigue was not reported. This report was non-serious.
HORRIBLE ITCHING; SORES ALL OF BODY; This spontaneous report received from a patient via a company representative concerned a 7 decade old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker, and non alcohol user, and other pre-existing medical conditions included: The patient did not had known drug allergies and drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 7 decade old. No concomitant medications were reported. On 2021, the patient experienced horrible itching, and sores all of body. Laboratory data (dates unspecified) included: Blood test could not find anything was allergic too. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from horrible itching, and sores all of body. This report was non-serious. This case is a duplicate of 20230207847.
felt a little more sluggish after the booster, more than the other two doses,; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (felt a little more sluggish after the booster, more than the other two doses,) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 001C21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (felt a little more sluggish after the booster, more than the other two doses,). At the time of the report, SLUGGISHNESS (felt a little more sluggish after the booster, more than the other two doses,) had resolved Patient  also stated that he felt a little more sluggish after the booster, more than the other two doses, and that it indicates that he had a lot of antibodies.  Concomitant medications were not reported. Treatment medications were not reported.
A 73 year old male patient got his first Shingrix vaccine in the pharmacy on 04/19/23. He presented 05/04/2023 to pick up a topical corticosteroid prescription to treat a red blotchy rash on his arms and trunk that he said appeared the day after the vaccination.
DAY AFTER SECOND DOSE - GOT CHILLS/FEVER/HEADACHE SEVEN DAYS LATER DEVELOP SEVERE HEADACHES, FEVER BLISTER -CANKER SORE IN THE RIDE SIDE OF MY CHIN - CHILLS/FEVER 101-103 - SWOLLOW LYMPH NOSE AND KNOTS IN THE BACK OF NECK AND TENDER RISE INTHE LEFT SIDE   MY HEAD.
pt recvd vax 28DEC92 & the same day devel a red raised, itchy, rash on rt arm & back; treated w/Atarax; got better w/in 3 days;
Patient presented to the emergency room with a complaint of not feeling well: Dizziness, weakness, nausea, but no abdominal pain, fever, melena or hematemesis..  With a history of diabetes mellitus type 2, hypertension, Nash syndrome, coronary artery disease. He underwent an EGD/ERCP during which multiple stones were removed and the patient had bleeding at his sphincterotomy site requiring treatment with a self-expandable metal stent. He was discharged on Augmentin with plan for outpatient cholecystectomy. ED visit and hospital admissions within 6 weeks of receiving the COVD vaccine.
Information has been received from a medical assistant referring to a 29 year old female patient. The patient's medical history, concurrent condition and concomitant medication were unknown. On 29-JUL-2016, the patient was inadvertently vaccinated with a dose of (Oka-Merck) PROQUAD (strength, dose and frequency unknown, lot # M015700, expiration date: 26-SEP-2017) subcutaneously instead of a dose of (Wistar RA 27-3) M-M-R II. The nurse was not aware that there was a difference between (Oka-Merck) PROQUAD and (wistar RA 27-3) M-M-R II (Product label confusion). No adverse effects were reported. Additional information has been requested.
patient presented with 114/70 BP, 95% SP02, 79 HR. patient felt sweaty and dizzy. Ate food and felt better. observed for additional fifteen minutes. BP when leaving 114/72.
extreme tiredness - couldn't stay awake bad headache all day on 1/6 muscle aches and pains, nausea, chills - no fever pain in arm, pain under arm
Pt developed redness, pain, swelling, and warmth to vaccine site day after vaccine administered.